bioengineer.org /1 week ago

Biobank Lymphoblastoid Cell Reprogramming Opens New Pathways for Human Disease Modeling

A comprehensive review examines fifteen years of reprogramming lymphoblastoid cell lines into induced pluripotent stem cells, tracing methodological advances, biobank scalability,...

Read source
fightaging.org /2 weeks ago

Circular RNA Encoding Yamanaka Factors Enables Partial Reprogramming Without Pluripotency

At the high level, exposing a cell to the Yamanaka factors first does nothing, then later rejuvenates epigenetic control over nuclear DNA structure and gene expression, and then la...

Read source
asia.nikkei.com /1 month ago

Japan aims to develop 'next-gen' iPS cells for strokes and kidney failure

Read source
genengnews.com /1 month ago

iPSC Manufacturing Starts with the Source

For iPSC developers, scalable manufacturing begins long before the bioreactor. Pluristyx leaders explain why starting material, process discipline, automation, and shared data will...

Read source
newsonjapan.com /3 weeks ago

First Parkinson's Patient Receives iPS Cell Treatment at Kyoto University Hospital

Japanese pharmaceutical company Sumitomo Pharma announced on October 30 that the first patient to receive its newly approved regenerative medicine treatment for Parkinson's disease...

Read source
newsonjapan.com /1 month ago

World’s First iPS Cell Heart Surgery Performed in Osaka

A woman in her 50s with severe heart failure underwent what was described as the world's first surgery using commercially available iPS cell-derived heart muscle sheets at an Osaka...

Read source
bioengineer.org /4 weeks ago

Partial Cell Reprogramming Shields Aging Mouse Brains from Ischemic Stroke Damage

Cyclic induction of the Yamanaka reprogramming factors for four weeks before stroke reduced ischemic brain damage, preserved neurons and myelin, and improved forelimb motor scores...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.